Effect of Spironolactone in Resistant Arterial Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial (ASPIRANT-EXT)

This study was designed to assess the effect of the addition of low-dose spironolactone on blood pressure (BP) in patients with resistant arterial hypertension. Patients with office systolic blood pressure (SBP) >140 mm Hg or diastolic blood pressure (DBP) >90 mm Hg despite treatment with at l...

Descripción completa

Detalles Bibliográficos
Autores principales: Václavík, Jan, Sedlák, Richard, Jarkovský, Jiří, Kociánová, Eva, Táborský, Miloš
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2014
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602792/
https://www.ncbi.nlm.nih.gov/pubmed/25501057
http://dx.doi.org/10.1097/MD.0000000000000162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602792/
https://www.ncbi.nlm.nih.gov/pubmed/25501057
http://dx.doi.org/10.1097/MD.0000000000000162

Ejemplares similares